NeoGenomics, Inc.
NEO · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | July 28, 2026 | — | 196.93M | — | 0.03 | — |
| 2026 Q1 | April 28, 2026 | 186.67M | 184.54M | -0.13 | 0.01 | -0.67% |
| 2025 Q4 | February 17, 2026 | 190.17M | 188.50M | -0.08 | 0.04 | +0.53% |
| 2025 Q3 | October 28, 2025 | 187.80M | 188.25M | -0.05 | 0.02 | -2.36% |
| 2025 Q2 | July 29, 2025 | 181.33M | 183.85M | -0.06 | 0.03 | -18.73% |
| 2025 Q1 | April 29, 2025 | 168.04M | 182.94M | -0.08 | -0.02 | -34.00% |
| 2024 Q4 | February 18, 2025 | 172.00M | 172.59M | -0.02 | 0.02 | -13.97% |
| 2024 Q3 | November 5, 2024 | 167.82M | 173.09M | -0.02 | 0.01 | +5.59% |
| 2024 Q2 | July 29, 2024 | 164.50M | 166.63M | -0.04 | 0.00 | +17.96% |
| 2024 Q1 | April 30, 2024 | 156.24M | 162.22M | -0.08 | -0.03 | -8.54% |
| 2023 Q4 | February 20, 2024 | 155.55M | 152.53M | -0.02 | -0.01 | +12.11% |
| 2023 Q3 | November 6, 2023 | 151.95M | 142.00M | -0.06 | -0.06 | +14.20% |
| 2023 Q2 | August 8, 2023 | 146.92M | 137.42M | -0.09 | -0.10 | -3.04% |
| 2023 Q1 | May 8, 2023 | 137.22M | 126.39M | -0.13 | -0.14 | +18.51% |
| 2022 Q4 | February 23, 2023 | 138.71M | 129.97M | -0.10 | -0.15 | +24.57% |
| 2022 Q3 | November 8, 2022 | 128.78M | 121.54M | -0.17 | -0.19 | +25.35% |